Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions

Authors

• David Dauer, Sartorius Stedim Biotech GmbH, Germany
• Ana-Raquel Fortuna, Sartorius Stedim Biotech GmbH, Göttingen, Germany
• Florian Taft, Sartorius Stedim Biotech GmbH, Göttingen, Germany
• André Krause, Sartorius Stedim Biotech GmbH, Göttingen, Germany
• Michael Wolff, Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Gießen, Germany
• Udo Reichl, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
• Volkmar Thom, Sartorius Stedim Biotech GmbH, Göttingen, Germany

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

David Dauer, Ana-Raquel Fortuna, Florian Taft, André Krause, Michael Wolff, Udo Reichl, and Volkmar Thom, "Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/20